Immunotherapy improves efficacy and safety of patients with HPV positive and negative head and neck cancer: A systematic review and meta-analysis

Marisol Miranda Galvis,Gabriel Alvares Borges,Thiago Bueno de Oliveira,Isabela Porto de Toledo,Rogerio Moraes Castilho,Eliete Neves Silva Guerra,Luiz Paulo Kowalski,Cristiane Helena Squarize

Critical Reviews in Oncology/Hematology（2020）

引用 0|浏览1

暂无评分

摘要

•Immunotherapy significantly improves overall survival and response rate of patients with head and neck squamous cell carcinoma.•Immunotherapy is most beneficial for patients with HPV and PD-L1 positive head and neck tumors.•Immunotherapy results in lower rates of treatment-related adverse events and toxicity.

查看译文

关键词

Head and neck squamous cell carcinoma,Immunotherapy,Human papillomavirus,Programmed death-ligand 1,Toxicity,Meta-analysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要